GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Gencurix Inc (XKRX:229000) » Definitions » Cash Flow for Lease Financing

Gencurix (XKRX:229000) Cash Flow for Lease Financing : ₩-194 Mil (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Gencurix Cash Flow for Lease Financing?

Gencurix's Cash Flow for Lease Financing for the three months ended in Mar. 2024 was ₩0 Mil. Gencurix's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-194 Mil.

Compared with last quarter (₩-40 Mil in Dec. 2023 ), Gencurix's Cash Flow for Lease Financing increased in Mar. 2024 (₩0 Mil).

Gencurix Cash Flow for Lease Financing Historical Data

The historical data trend for Gencurix's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gencurix Cash Flow for Lease Financing Chart

Gencurix Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Lease Financing
Get a 7-Day Free Trial -234.08 -294.40 -417.42 -368.94 -193.93

Gencurix Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -60.66 -55.94 -37.60 -39.73 -

Gencurix Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-194 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gencurix Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Gencurix's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Gencurix (XKRX:229000) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Gencurix Inc (XKRX:229000) » Definitions » Cash Flow for Lease Financing
Comparable Companies
XKRX:347740 XKRX:031860 XKRX:109820 XKRX:221800 XKRX:245620 XKRX:086040 XKRX:303360 XKRX:246250 XKRX:253840 XKRX:122310 TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
N/A
Address
9th Floor, Hanhwa Bizmetro I, Guro 3-dong, Guro-gu, Seoul, KOR, 152-733
Website
http://www.gencurix.com
Gencurix Inc develops diagnosis treatment kits. It offers products including GenesWell BCT, a breast cancer test; GenesWell ddEGFR Mutation Test; GenesWell CDx EGFR Mutation Test; and GenesWell ddEGFR mutation Test.

Gencurix (XKRX:229000) Headlines

No Headlines